The GMP Engineering & Cell Manufacturing Facility (GEM) provides cutting-edge clean rooms, cell therapy equipment, manufacturing know-how, robust capabilities and comprehensive suite of quality assurance and control procedures.

This state-of-the-art facility provides advanced flow cytometric and morphology services at cellular and subcellular levels of resolution. The services offered by the Flow and Immune Analysis Shared Resource (FIASR) include investigator access to equipment 24/7, education and consultation services, comprehensive sample processing, data acquisition and data analysis services, luminex cytokine, chemokine and growth factor quantification, and core flow cytometry services for investigator and biotech sponsored clinical trials.

The Biomedical Research Informatics Shared Resource (BRISR) provides consultations and services for investigators and study teams in the areas of clinical research, informatics, and data science. BRISR helps researchers harness internal and external data resources and provide informatics-driven solutions for clinical and translational research.

We offer the infrastructure and processes to establish and monitor data standards, quality, integration and distribution across Roswell Park and aim to make research findable, accessible, interoperable, and reusable (FAIR). Additionally, BRISR offers educational and training opportunities. We provide services in three main areas: (1) Clinical data management and delivery for research, (2) Custom software development for research, and (3) Artificial intelligence analysis for clinical and bioinformatics research.

The Gene Targeting and Transgenic Shared Resource (GeTT) enables investigators to modify the murine genome for the systematic dissection of the genetic, molecular, cellular and physiological mechanisms underlying complex biological processes.

Traditionally, this has been done by creation of transgenics through pronuclear microinjection and knocking out or knocking in genes via mouse ES cell technologies.

This is no longer the case given the recent advances of genome-editing tools such as ZFNs, TALENs and most recently CRISPR/Cas, which allow for a targeted approach by injection directly into the embryo.

In general, these methods are proving to be faster and more efficient than traditional means.

In addition, the core also provides investigators with mouse reproductive services such as cryopreservation of valuable mouse strains and IVF (in vitro fertilization) to aid in mouse cohort generation, especially when faced with increasing complex genotype demands.

The Genomics Shared Resource (GSR) offers sample-to-data services, with an expert technical staff performing all aspects of sample preparation, QC, assay design and analysis.

The GSR is a broadly functioning core that provides an integrated set of tools and services for genomic analysis. Our long-standing history and contribution to the Human Genome Program through clone generation, high throughput mapping, array technology development and distribution of these resources worldwide provides a track record documenting our expertise.

The suite of technology and platform offerings virtually encompasses all available genomics platforms, allowing tremendous flexibility and complete research solutions including full-service sample to data offerings, training and education on instruments and methodologies, complete discovery/screening to validation services, and full Laboratory Information Management System (LIMS) request, workflow and sample management.

The Bioanalytics, Metabolomics & Pharmacokinetics Shared Resource (BMPK) provides highly sensitive measurements for an extensive array of chemotherapeutic agents and metabolites to support basic research and preclinical/clinical drug development, in addition to other cancer centers, academic institutions, and industry.